Navigation Links
UniqueU Medical Weight Loss Success Requires an Expansion and Move to a Larger Location
Date:5/4/2010

In an effort to keep up with increased business and new patient traffic, the UniqueU Medical Weight Loss Program will be moving into a bigger office location on April 26.

Cincinnati, OH (PRWEB) May 4, 2010 -- The continued success of the UniqueU Medical Weight Loss Program is requiring the office to relocate to a larger facility away from their existing location on Pine Road in Kenwood. The office now occupies a shared space with the two doctors who introduced UniqueU to the Cincinnati area, Dr. Dan Buchanan, DC and Dr. James Lutz, MD. Both are excited about the growth of this cutting-edge diet phenomenon.

The new office will be located at 4760 Red Bank Road, Suite 238, just off the Red Bank Road exit from I-71. One of the benefits of the additional space will be a dedicated staff specializing exclusively to the needs of the dieter.

The UniqueU Medical Weight Loss Program was first introduced to the Cincinnati area in January of this year. The acceptance and growth of the program has been incredible.

This four-phase, multi-faceted program begins with a medical examination, blood work and an EKG to insure patients are medically fit. With ground-breaking appetite suppressants, light exercise and unique use of the hormone HCG, this program has been called a “medical miracle diet.” For both women and men who typically have excess weight on their belly, butt and thighs, the HCG targets stored fat, not muscle. The results are rapid weight loss, decreased appetite and an amazing outcome for the typical diet dropout. An added element of support and education continues once the ideal weight has been reached.

“We are thrilled to have to expand to a larger location,” said Dr. Dan Buchanan. “The patients we see each week are continuing to lose weight and they tell their friends and family about the long-term benefits of the UniqueU Medical Weight Loss Program. We are growing because of so many satisfied patients.”

While HCG diets are not a new thing, the combination of medical supervision, supplements, appetite suppressants and education all work together to provide a whole life-changing program for people who have struggled to lose weight and failed. This combination is what many the patients believe makes the difference in their success. The quick weight loss experience by most patients eliminates the frustration of sticking to a diet for a long period of time. It is a win-win situation for health and overall well-being.

For additional information on this program or to schedule an interview with either of the doctors, please call 513-984-2700. UniqueU Medical Weight Loss Program’s new location will be 4760 Red Bank Road, Cincinnati, OH 45227, effective April 26, 2010.

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb3954364.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. UniqueU Medical Weight Loss Program Opens Cincinnati Location
2. Recorders.com Offers Free Dragon Medical 10.1 Upgrades
3. Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
4. FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
5. Summit Medical Group hosts “Go Red Day” to Raise Awareness of Heart Disease and Stroke
6. LocumTenens.com Sponsors Medical Brigades to Honduras
7. Striking Down Medical Liability Reforms Another Blow to Illinois Poor Lawsuit Climate
8. Operation Smile Expands Its Medical Efforts to Help Earthquake Victims in Haiti
9. Statement From IHA President Maryjane A. Wurth on Illinois Supreme Court Medical Liability Ruling
10. Emergo Group Acquires UK-based Mediqol Ltd.; Greatly Expands Medical Device Consulting Presence in Europe
11. Summit Medical Group Physician Named "Nurses Choice: Top Doctor"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... ... Cellairis is a worldwide mobile device and computer repair franchise that is known ... Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up for business ... customers. While customers do their shopping, Cellairis can accomplish a number of mobile device ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, ... safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP FOR ... easy to use and could be set up in a matter of minutes, or ...
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: